Thiazolidinediones
Showing 26 - 50 of 204
Type 2 Diabetes Trial in Mexico (Glimepiride / Vildagliptin / Metformin (2 mg/ 50 mg/ 1000 mg), Glimepiride / Vildagliptin /
Not yet recruiting
- Type 2 Diabetes
- Glimepiride / Vildagliptin / Metformin (2 mg/ 50 mg/ 1000 mg)
- Glimepiride / Vildagliptin / Metformin (4 mg/ 50 mg/ 1000 mg)
-
CancĂșn, Quintana Roo, Mexico
- +4 more
Jun 8, 2021
Patients Infected With COVID-19 Trial in Granada (Vitamin D)
Unknown status
- Patients Infected With COVID-19
- Vitamin D
-
Granada, Andalucia, Spain
- +1 more
Apr 3, 2020
s on Risk of Heart Failure Hospitalization and Amputation for
Completed
- Diabetes Mellitus, Type 2
- Cardiovascular Diseases
- Canagliflozin
- +8 more
-
Titusville, New JerseyJanssen Investigative Site
Aug 24, 2018
Type2 Diabetes Trial in Beijing (Glucophage 500Mg Tablet, Acarbose Tablets, Sitagliptin tablet)
Unknown status
- Type2 Diabetes Mellitus
- Glucophage 500Mg Tablet
- +5 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Feb 26, 2020
Sodium-glucose Cotransporter 2 Inhibitors Among Type 2 Diabetes
Completed
- Diabetes Mellitus, Type 2
- +3 more
- Sodium-glucose cotransporter 2 (SGLT2) inhibitors
- +2 more
-
Montreal, Quebec, CanadaLady Davis Institute for Medical Research, Jewish General Hospit
Aug 17, 2020
Diabetes, Chronic Disease, Psychological Distress Trial in Chapel Hill (Immediate Chronic Disease Prevention Program (CDPP),
Recruiting
- Diabetes
- +2 more
- Immediate Chronic Disease Prevention Program (CDPP)
- +2 more
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Dec 9, 2022
Heart Failure, Diabetes Trial in Los Angeles (Metformin)
Completed
- Heart Failure
- Diabetes
-
Los Angeles, CaliforniaAhmanson-UCLA Cardiomyopathy Center
Aug 20, 2020
Diabetic Neuropathies Trial in Islamabad (SLP, SLP along with Physiotherapy, Physiotherapy)
Recruiting
- Diabetic Neuropathies
- SLP
- +2 more
-
Islamabad, Federal, PakistanPakistan Railway Hospital
Mar 21, 2021
Type 2 Diabetes Trial in Canada, United States (Bexagliflozin, Placebo)
Completed
- Type 2 Diabetes Mellitus
- Bexagliflozin
- Placebo
-
Canoga Park, California
- +22 more
Jun 2, 2021
Polycystic Ovary Syndrome Trial in Shiraz (Cyproterone compound + Spironolactone, Metformin, Pioglitazone)
Completed
- Polycystic Ovary Syndrome
- Cyproterone compound + Spironolactone
- +2 more
-
Shiraz, Fars, Iran, Islamic Republic ofShahid Motahhari Clinic, Shiraz University of Medical Sciences
Nov 8, 2019
Systemic Lupus Erythematosus Trial run by the NIAMS (PET/CT, Pioglitazone, Placebo)
Completed
- Systemic Lupus Erythematosus
- PET/CT
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 23, 2021
Sodium-glucose Cotransporter 2 Inhibitors and Risk of
Completed
- Type2 Diabetes
- +5 more
- Sodium-glucose cotransporter 2 (SGLT2) inhibitors
- Dipeptidyl peptidase-4 (DPP-4) inhibitors
-
Montreal, Quebec, CanadaLady Davis Institute for Medical Research, Jewish General Hospit
Oct 1, 2020
Diabetes, Type 2 Trial in Prague (Metformin Oral, Metformin local in AT, Exercise)
Completed
- Diabetes Mellitus, Type 2
- Metformin Oral
- +2 more
-
Prague, CzechiaThird Faculty of Medicine, Charles University
Feb 12, 2020
Squamous Cell Carcinoma of the Skin Trial (Pioglitazone)
Completed
- Squamous Cell Carcinoma of the Skin
- (no location specified)
Jun 2, 2020
T1DM Trial (Hyperbaric oxygen chamber (HBOC), sham Hyperbaric oxygen chamber (HBOC))
Not yet recruiting
- T1DM
- Hyperbaric oxygen chamber (HBOC)
- sham Hyperbaric oxygen chamber (HBOC)
- (no location specified)
Jun 1, 2020
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, alpha-glucosidase inhibitors, DPP-4 inhibitors)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- +6 more
-
Birmingham, Alabama
- +231 more
Jun 16, 2020
Fracture Risk With Thiazolidinediones
Completed
- Fractures, Bone
- Type II Diabetes
- TZD only (RSG or PIO or troglitazone)
- +2 more
- (no location specified)
May 25, 2017
Insulin Resistance Trial (Metformin group, Rosiglitazone group, Placebo oral tablet)
Completed
- Insulin Resistance
- Metformin group
- +2 more
- (no location specified)
Oct 31, 2019
Obesity, Diabetes, Type 2 Trial in Oldenburg, Hamburg (Dapagliflozin 10mg, Exenatide 2 mg [Bydureon], Placebo Oral Tablet)
Terminated
- Obesity
- Diabetes Mellitus, Type 2
- Dapagliflozin 10mg
- +5 more
-
Oldenburg, Lower Saxony, Germany
- +3 more
Mar 29, 2020
Diabetes, Type 2 Trial in Guadalajara (Exenatide LAR, Dulaglutide)
Unknown status
- Diabetes Mellitus, Type 2
- Exenatide LAR
- Dulaglutide
-
Guadalajara, Jalisco, MexicoInstituto de terapeutica Experimental y Clinica. Centro universi
Mar 24, 2020
Type 2 Diabetes Trial in Guangzhou (Complications assessment)
Unknown status
- Type 2 Diabetes Mellitus
- Complications assessment
-
Guangzhou, Guangdong, Chinaendocrinology department of the first affiliated hospital of Sun
Apr 6, 2019
Type 2 Diabetes Trial in Korea, Republic of (vildagliptin, Pioglitazone)
Completed
- Type 2 Diabetes
-
Busan, Korea, Republic of
- +14 more
Dec 13, 2018
Diabetes, Pulmonary Tuberculosis Trial in Bandung, Lima, Bucharest (intensive monitoring)
Completed
- Diabetes Mellitus
- Pulmonary Tuberculosis
- intensive monitoring
-
Bandung, West Java, Indonesia
- +2 more
Apr 17, 2019